Regulatory bodies like Anvisa are crucial for approving new medications. Their decisions are based on established, standardized procedures and rigorous data analysis from clinical trials, not on individual opinions. A researcher must present sufficient evidence to Anvisa, which then evaluates it against global standards to determine if a drug is safe and effective for public use, ensuring a consistent and reliable approval process.
Impact: High. Anvisa's adherence to standardized, evidence-based procedures ensures public safety by preventing the approval of ineffective or harmful treatments, maintaining trust in the healthcare system.
In the source video, this keypoint occurs from 02:11:38 to 02:13:24.
Sources in support: Emílio Garcia (Biologist)

